retatrutide clinical results 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 New Phase 3 are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of Retatrutide vs Tirzepatide (2026): Differences

GLP-1 receptors are found throughout the body and within the brain and can have multi-system effects, including our reward-based eating

The GLP-1 peptide is attached to an antibody, which acts like a protective carrier

GLP-1 Vision Loss Lawsuits In January, the same judge was also put in charge of a growing number of GLP-1 vision loss lawsuits, a smaller, but growing, litigation that began after a series of studies linked semaglutide-based drugs, like Ozempic, Wegovy and Rybelsus, to being associated with a condition known as non-arteritic anterior ischemic optic neuropathy (NAION)

Rakhra V, Galappaththy SL, Bulchandani S, Cabandugama PK

Supportive staff that has only one goal